Investment House LLC Regeneron Pharmaceuticals, Inc. Transaction History

Investment House LLC

$1.72 Billion
Q1 2025

A detailed history of Investment House LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Investment House LLC holds 689 shares of REGN stock, worth $411,016. This represents 0.03% of its overall portfolio holdings.

Number of Shares

689

Previous 689 -0.0%

Holding current value

$411,016

Previous $490,000 11.02%

% of portfolio

0.03%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1024.09 - $1201.76 $10,240 - $12,017	-10 Reduced 1.43%	689 $724,000
Q4 2023 Feb 05, 2024	SELL	$775.18 - $881.7 $12,402 - $14,107	-16 Reduced 2.24%	699 $613,000
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $311,602 - $379,966	-450 Reduced 38.63%	715 $588,000
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $17,219 - $21,729	-30 Reduced 2.51%	1,165 $803,000
Q2 2020 Jul 13, 2020	SELL	$493.32 - $643.92 $7,399 - $9,658	-15 Reduced 1.24%	1,195 $745,000
Q1 2020 Apr 08, 2020	BUY	$336.18 - $494.43 $10,085 - $14,832	30 Added 2.54%	1,210 $591,000
Q4 2019 Feb 05, 2020	SELL	$274.13 - $376.51 $13,706 - $18,825	-50 Reduced 4.07%	1,180 $443,000
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $197,711 - $230,195	-723 Reduced 37.02%	1,230 $341,000
Q2 2019 Aug 05, 2019	SELL	$299.6 - $414.82 $17,976 - $24,889	-60 Reduced 2.98%	1,953 $611,000
Q1 2019 May 03, 2019	BUY	$372.08 - $439.57 $66,974 - $79,122	180 Added 9.82%	2,013 $827,000
Q4 2018 Feb 06, 2019	SELL	$335.82 - $403.04 $35,261 - $42,319	-105 Reduced 5.42%	1,833 $685,000
Q3 2018 Oct 09, 2018	SELL	$351.14 - $408.51 $1,755 - $2,042	-5 Reduced 0.26%	1,938 $783,000
Q2 2018 Jul 10, 2018	SELL	$284.6 - $344.99 $129,493 - $156,970	-455 Reduced 18.97%	1,943 $670,000
Q1 2018 May 08, 2018	BUY	$315.82 - $393.78 $757,336 - $944,284	2,398 New	2,398 $826,000

Others Institutions Holding REGN

# of Institutions

1,469

Shares Held

85.7M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $63.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Account

Investment House LLC Regeneron Pharmaceuticals, Inc. Transaction History